KKR crossed $98.97 this week, up 3.3% — and for the first time since February, the stock has pushed above the range where its Co-CEOs made their largest open-market purchases.
That insider buy cluster deserves revisiting. Co-CEOs Joseph Bae and Scott Nuttall each put up roughly $17–18 million across multiple tranches on February 17th, paying between $100 and $103 per share. Directors Timothy Barakett and Mary Dillon added another $6.7 million in early March at $91–$94. Total net insider buying over the 90-day window came to over $50 million. At $98.97, those February high-water buys are still modestly underwater, but the March purchases are now showing a gain — and the directional signal from management has been consistent throughout: they were buyers into weakness, not sellers into strength.
The positioning picture has shifted modestly since last week's note. Short interest eased another 3.6% on the week to 1.72% of the free float — roughly 15.3 million shares — continuing the gentle drift lower that began mid-June. That said, the month-long rebuild from 12.3 million shares in early May to the current level still represents a meaningful accumulation, and bears have not abandoned the trade. The lending market continues to offer them no friction. Availability remains effectively unlimited — over 414 million shares in the borrow pool against 15 million shorted — and cost to borrow, while up 15% on the week, remains trivially low at 0.38%. The short score of 32.8 keeps KKR in the bottom half of the universe on squeeze pressure. This is not a crowded short; it is a managed, low-cost bet.
Options traders are quietly turning less defensive. The put/call ratio has fallen to 1.81, below its 20-day average of 1.93 — the first sustained move below that average in weeks. The z-score of -1.49 confirms the shift is statistically meaningful. Relative to the past year's range of 0.98 to 2.18, the current reading is elevated in absolute terms but has been declining steadily since late May. The direction of travel matters more than the level here: options positioning is becoming less cautious as the stock recovers.
The Street remains constructively positioned, albeit with trimmed ambitions. The analyst consensus mean target is $125.53, implying roughly 27% upside from current levels — a wide gap that reflects both genuine conviction and the reality that most targets were set before the stock's April drawdown. Barclays and RBC both trimmed targets to $122–$128 in early May while keeping positive ratings. Morgan Stanley held its Overweight but cut to $153. UBS raised its Buy target to $126 from $113 after the Q1 print. The direction of the bull case is clear — flagship fundraising momentum, the $1 trillion AUM target by 2029, and the Capital Group partnership — while bears focus on Global Atlantic's insurance returns and near-term ANI/share compression. Forward EPS growth expectations remain strong, ranking in the 80th percentile on 12-month forward year-on-year increase, though near-term estimate momentum has been negative. The analyst recommendation differential factor score of 94 reflects a Street that is broadly positive and not capitulating.
Peer performance this week supports the broader alternative asset management bid. BX gained 6.3%, STEP surged 12.2%, and TPG added 3.4% — KKR's 3.3% move kept pace with most of the group but lagged the stronger names. ARES was the one notable outlier, slipping 0.3% on the day. The group-wide move suggests macro tailwinds rather than KKR-specific re-rating.
The next earnings event is August 4th. With the stock now back in the vicinity of insider purchase prices and options hedging easing, the conversation ahead of that print is less about whether demand for alternatives is structural and more about whether Global Atlantic's drag on near-term ANI/share is getting worse, stabilising, or reversing.
See the live data behind this article on ORTEX.
Open KKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
